Re-evaluation of Bleeding Events in the Japanese PRASFIT-Elective and PRASFIT-ACS Clinical Trials using the Bleeding Academic Research Consortium Criteria

Shunichi Miyazaki^1*, Takaaki Isshiki², Takeshi Kimura³, Hisao Ogawa⁴, Hiroyoshi Yokoi⁵, Masakatsu Nishikawa⁶, Masato Nakamura⁷, Yuko Tanaka⁸ and Shigeru Saito⁹

¹Department of Medicine, Faculty of Medicine, Kinki University, Osaka, Japan

²Ageo Central General Hospital, Ageo, Japan

³Graduate School of Medicine, Kyoto University, Kyoto, Japan

⁴Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto and National Cerebral and Cardiovascular Center, Suita, Osaka, Japan

⁵Fukuoka Sanno Hospital, Fukuoka, and International University of Health and Welfare, Tochigi, Japan

⁶Clinical Research Support Center, Mie University Hospital, Mie, Japan

⁷Division of Cardiovascular Medicine, Ohashi Medical Center, Toho University, Tokyo, Japan

⁸Clinical Data and Biostatistics Department, R&D Division, Daiichi Sankyo Co., Ltd, Tokyo, Japan

⁹Division of Cardiology, Shonan Kamakura General Hospital, Kamakura, Japan

^*Corresponding Author: